Montreal Gazette

Reducing Uncertaint­y Around themost Common Cancer in Canadian men

Taking early action against prostate cancer could prolong thousands of lives

- SOPHIE ASH Ask your doctor to monitor your psa levels closely and discuss treatment options to slow its progressio­n. Visit procure.ca to learnmore.

In 2017, 62-year-old Raymond Goyer’s family doctor noticed some abnormal results from his prostate-specific antigen, or PSA, test and referred him to a urologist for further investigat­ion.

Prostate-specific antigen is a protein made by the prostate. It’s normal to see small amounts of PSA in the blood, and some men have higher levels with no cause for concern. However, rising PSA levels can, in some cases, be indicative of prostate cancer so it’s important that men keep an eye on them – especially over the age of 50 and among highrisk individual­s.

Sure enough, a biopsy confirmed that Raymond had prostate cancer. He felt completely defeated. “It was localized to my prostate but very aggressive. Despite my doctor being empathetic, I felt like a train was passing through my head – like I’d been knocked out. I couldn’t listen to what he was saying,” Raymond recalls.

“I was not expecting the diagnosis at all. I didn’t have a family history of prostate cancer, nor had any of my friends spoken to me about it.”

Raymond’s prostate was surgically removed two months after he received his diagnosis. “There was a lot of uncertaint­y and I felt scared. I’m so thankful to have had my family there to support me,” says Raymond.

In the years that followed, Raymond experience­d a reoccurren­ce of his cancer, as witnessed by rising PSA levels, and was treated with a hormone therapy agent.

Raymond has been responding well to treatment. His urologist keeps a close eye on his PSA levels. Thankfully, his prostate cancer has not spread and he experience­s limited side-effects. “I’m always anxious to hear those results every 4 months. That’s probably the most difficult part of living with prostate cancer for me,” he reveals.

Being diagnosed earlier was likely a major contributi­ng factor to Raymond’s favourable health outcomes. The later the diagnosis, the higher the likelihood that prostate cancer will spread and that the individual will have a shorter life expectancy and poorer quality of life.

Raymond advises men to speak out if they have prostate cancer: “Once I started talking aboutmy experience, other men shared theirs too. We’re not alone.”

In fact, prostate cancer is the most common cancer among men. For instance, 12 men per day receive the diagnosis in Quebec. That’s over 4,300 Quebecers per year.

There are several types of prostate cancer and some are more aggressive than others. Not all types require treatment. Men at low risk of cancer progressio­n are, instead, subject to active medical surveillan­ce. But when early stage treatment is appropriat­e, the primary options are prostate removal, radiation therapy, and hormone therapy.

However, even if prostate cancer hasn’t spread to other parts of the body, it can become unresponsi­ve to treatment. For example, NMCRPC (non-metastatic castration-resistant prostate cancer) no longer responds to a medicine or surgery that lowers a male hormone called testostero­ne. If the cancer spreads, the chances of successful treatment, minimizing side effects, and maintainin­g a good quality of life dwindles even more.

Laurent Proulx, President and CEO of PROCURE, says rising PSA levels is the biggest indicator of prostate cancer. “PSA testing can help find prostate cancer early, when it’s easier to treat. It’s also key for measuring treatment success. Men should discuss ongoing PSA testing with their doctor and the best available treatment options for them,” Proulx remarks.

Dr. Fred Saad is the head of the Urology Department at the University ofmontreal Hospital Center. He says the first sign of prostate cancer is usually raised PSA levels or a rapidly rising PSA.

Dr. Saad advocates for treating aggressive prostate cancer as soon as possible but proposes active surveillan­ce for men with low risk cancers: “After the prostate has been treated, PSA should be close to zero. Therefore, it’s even more reliable to monitor in men treated for prostate cancer who are in remission.

There are many treatment options for prostate cancer. But, in order to explore and obtain access to them as quickly as possible, you need to know you have the disease or what state of health you’re in after you are diagnosed with the condition.

IWAS NOT EXPECTING THE DIAGNOSIS AT ALL. I DIDN’T HAVE A FAMILY HISTORY OF PROSTATE CANCER, NOR HAD ANY OF MY FRIENDS SPOKEN TO ME ABOUT IT

 ?? GETTY ?? Prostate cancer is the most common cancer among men. For instance, 12 men per day receive the diagnosis in Quebec
GETTY Prostate cancer is the most common cancer among men. For instance, 12 men per day receive the diagnosis in Quebec

Newspapers in English

Newspapers from Canada